Below are Freedom of Information Act (FOIA) requests filed by KEI related to issues concerning the coronavirus/COVID-19 pandemic. This page will be updated as we file requests and receive responses.
Department of Health and Human Services
Centers for Disease Control and Prevention (CDC)
- Filed March 20, 2020. Records related to remdesivir grant. STATUS: Awaiting acknowledgement.
Biomedical Advanced Research and Development Authority (BARDA)
- Filed March 20, 2020. Records related to remdesivir grant. STATUS: Awaiting acknowledgement.
- Filed March 25, 2020. Records concerning “Other Transaction Authority” contract with Johnson&Johnson for novel coronavirus vaccine. STATUS: Awaiting Acknowledgement.
- Filed March 25, 2020. Records concerning “Other Transaction Authority” contract with Regeneron Bio for novel coronavirus vaccine. STATUS: Awaiting Acknowledgement.
- Filed April 9, 2020. Records concerning all contracts in BARDA’s Novel Coronavirus Medical Countermeasure Portfolio. STATUS: Acknowledged April 9, 2020.
Food and Drug Administration (FDA)
- Filed March 25, 2020. Records concerning Gilead Sciences’ remdesivir orphan drug designation application and FDA’s review of the application. STATUS: Awaiting Acknowledgement.
National Institutes of Health (NIH)
- Filed April 17, 2020. Records concerning the Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) partnership between the NIH, the Foundation for the NIH, HHS Office of the Assistant Secretary for Preparedness and Response, U.S. Food and Drug Administration, Centers for Disease Control and Prevention, European Medicines Agency, and 16 pharmaceutical companies. STATUS: Acknowledged April 17, 2020.
National Cancer Institute (NCI)
- Filed March 20, 2020. Records related to remdesivir grant. STATUS: Final response received March 23, 2020. Records under review by KEI.
National Institute of Allergy and Infectious Diseases (NIAID)
- Filed March 20, 2020. Records related to remdesivir grant. STATUS: Acknowledged March 20, 2020.
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Filed March 20, 2020. Records related to remdesivir grant. STATUS: Acknowledged March 20, 2020.
Department of Defense
United States Army Medical Research Institute of Infectious Diseases (USAMRIID)
- Filed March 23, 2020. Records related to remdesivir grant. STATUS: Awaiting acknowledgement.
Defense Health Agency (DHA)
- Filed March 25, 2020. Records related to Ology Bioservices contract with DoD via Defense Health Agency to work with Inovio Pharmaceuticals to manufacture a COVID-19 DNA vaccine. STATUS: Awaiting Acknowledgement.
For more on KEI’s work on COVID-19, see keonline.org/coronavirus.